Trade Harvard Bioscience - HBIO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0175 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.3804 |
| Open | 0.3702 |
| 1-Year Change | -89.94% |
| Day's Range | 0.3675 - 0.3797 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 0.3697 | -0.0031 | -0.83% | 0.3728 | 0.3805 | 0.3633 |
| Apr 24, 2025 | 0.3804 | -0.0025 | -0.65% | 0.3829 | 0.3909 | 0.3754 |
| Apr 23, 2025 | 0.3881 | -0.0047 | -1.20% | 0.3928 | 0.4164 | 0.3878 |
| Apr 22, 2025 | 0.3840 | 0.0281 | 7.90% | 0.3559 | 0.3858 | 0.3529 |
| Apr 21, 2025 | 0.3579 | -0.0249 | -6.50% | 0.3828 | 0.3828 | 0.3528 |
| Apr 17, 2025 | 0.3784 | -0.0044 | -1.15% | 0.3828 | 0.3928 | 0.3690 |
| Apr 16, 2025 | 0.3851 | -0.0141 | -3.53% | 0.3992 | 0.4096 | 0.3835 |
| Apr 15, 2025 | 0.3877 | 0.0068 | 1.79% | 0.3809 | 0.4028 | 0.3809 |
| Apr 14, 2025 | 0.3915 | -0.0013 | -0.33% | 0.3928 | 0.4131 | 0.3803 |
| Apr 11, 2025 | 0.3891 | 0.0140 | 3.73% | 0.3751 | 0.3905 | 0.3652 |
| Apr 10, 2025 | 0.3784 | -0.0574 | -13.17% | 0.4358 | 0.4358 | 0.3635 |
| Apr 9, 2025 | 0.4452 | 0.0724 | 19.42% | 0.3728 | 0.4788 | 0.3577 |
| Apr 8, 2025 | 0.3728 | -0.0503 | -11.89% | 0.4231 | 0.4231 | 0.3442 |
| Apr 7, 2025 | 0.3738 | -0.0105 | -2.73% | 0.3843 | 0.4193 | 0.3576 |
| Apr 4, 2025 | 0.3930 | -0.0476 | -10.80% | 0.4406 | 0.4406 | 0.3789 |
| Apr 3, 2025 | 0.4660 | -0.0750 | -13.86% | 0.5410 | 0.5528 | 0.4404 |
| Apr 2, 2025 | 0.5769 | 0.0141 | 2.51% | 0.5628 | 0.5878 | 0.5628 |
| Apr 1, 2025 | 0.5828 | -0.0176 | -2.93% | 0.6004 | 0.6004 | 0.5528 |
| Mar 31, 2025 | 0.5582 | -0.0334 | -5.65% | 0.5916 | 0.5916 | 0.5582 |
| Mar 28, 2025 | 0.5928 | 0.0150 | 2.60% | 0.5778 | 0.6034 | 0.5778 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Harvard Bioscience Company profile
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a developer, manufacturer, and seller of technologies, products and services that enable fundamental research, discovery, and preclinical testing for drug development. The Company provides products that support research in six different classes of laboratory use, including molecular, cellular, tissue, organ, organisms, and clinical. The Company primarily sells its products under several brand names, including Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The Company’s customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs, and government researchers.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Harvard Bioscience, Inc. revenues increased 16% to $118.9M. Net loss decreased 96% to $288K. Revenues reflect United States segment increase of 18% to $49.8M, Europe segment increase of 19% to $35.8M. Lower net loss reflects Interest expense decrease of 68% to $1.5M (expense), G/L on early Exting of lease relat debt decrease from $1.9M (expense) to $0K.
Equity composition
Common Stock $.01 Par, 12/10, 80M auth., 36,057,974 issd., less 7,745,507 shs. in Treas. @ 10.7M. Insiders & Strategic holders own 13.56%. IPO: 12/7/2000, 6,420,000 shs. @$8 by Thomas Weisel Partners LLC. *NOTE: 10/02, Company acquired Genomic Solutions, Inc. @ 0.1017 shares and $0.286 in cash (3,178,857 shares issd.).
| Industry: | Advanced Medical Equipment & Technology (NEC) |
84 October Hill Rd
HOLLISTON
MASSACHUSETTS 01746-1371
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com